Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

TSXV:VPT - Post Discussion

VentriPoint Diagnostics Ltd > insider awards
View:
Post by bluemoons20 on Jan 22, 2022 1:44pm

insider awards

Very nice to reward insiders  with options  under the market price.

However, to encourage  them  to work for their money, the  options etc,.  should be priced  above the current market  to  provide incentive to  raise the  shareprice and benefit themselves and the  shareholders , who are  actually  paying the bills.

This way  they  have a guaranteed gain  and only have to  hope  the price does  not go down  but  if it doesn't go up they are still OK.

If  we do eventually  get a buyout  you can bet  these 8 miullion options  will be right there to pick up their gain.  And this will further  dilute  the per share  buyout price  (if it exists)

GLTA shareholders
Comment by InvrsContrarian on Jan 22, 2022 10:03pm
I don't see what you are saying as true. Maybe for the old older option. But recently:"Jan. 20, 2022, Ventripoint Diagnostics Ltd. granted an aggregate of 1,725,000 options to directors, officers, employees, contractors and consultants of the corporation with an exercise price of 40 cents and with terms from one to 10 years and vesting from immediately to over three years. Of these option ...more  
Comment by bluemoons20 on Jan 23, 2022 9:54am
apologies,   yes  , the latest ones  were  @  40 cents.   Misread  too quickly  but  weighted average price of outstanding options is  27  cents.   So still a lot of potential dilution out there. just seems that the  potential  buyout  price per share  gets lower and lower as time goes on. GLTA
Comment by Enough on Jan 23, 2022 1:06pm
Yes there are some at the higher price , but the average prioce granted seems to me under the m,arket price... so I see it like Blue Moon Elsewhere in  the  report: "There are currently 8,958,750 option grants outstanding with exercise prices between $0.10 to $0.50 with a weighted average price of $0.27, and 5,037,500 of these options have vested. Since the last update (see ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities